JP2005515155A5 - - Google Patents

Download PDF

Info

Publication number
JP2005515155A5
JP2005515155A5 JP2002592867A JP2002592867A JP2005515155A5 JP 2005515155 A5 JP2005515155 A5 JP 2005515155A5 JP 2002592867 A JP2002592867 A JP 2002592867A JP 2002592867 A JP2002592867 A JP 2002592867A JP 2005515155 A5 JP2005515155 A5 JP 2005515155A5
Authority
JP
Japan
Prior art keywords
lecithin
antibiotic
group
composition
combinations
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2002592867A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005515155A (ja
JP5051865B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2002/016428 external-priority patent/WO2002096354A2/en
Publication of JP2005515155A publication Critical patent/JP2005515155A/ja
Publication of JP2005515155A5 publication Critical patent/JP2005515155A5/ja
Application granted granted Critical
Publication of JP5051865B2 publication Critical patent/JP5051865B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2002592867A 2001-05-29 2002-05-28 レシチンでのプロドラッグエステル非乳化調合物の経口バイオアベイラビリティの向上 Expired - Fee Related JP5051865B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US86735301A 2001-05-29 2001-05-29
US29414101P 2001-05-29 2001-05-29
US60/294,141 2001-05-29
US09/867,353 2001-05-29
PCT/US2002/016428 WO2002096354A2 (en) 2001-05-29 2002-05-28 Enhancement of oral bioavailability of non-emulsified formulation of prodrug esters with lecithin

Publications (3)

Publication Number Publication Date
JP2005515155A JP2005515155A (ja) 2005-05-26
JP2005515155A5 true JP2005515155A5 (https=) 2006-01-05
JP5051865B2 JP5051865B2 (ja) 2012-10-17

Family

ID=26968357

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002592867A Expired - Fee Related JP5051865B2 (ja) 2001-05-29 2002-05-28 レシチンでのプロドラッグエステル非乳化調合物の経口バイオアベイラビリティの向上

Country Status (5)

Country Link
EP (1) EP1401402B1 (https=)
JP (1) JP5051865B2 (https=)
CA (1) CA2449002C (https=)
MX (1) MXPA03010945A (https=)
WO (1) WO2002096354A2 (https=)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1555024B1 (en) 2002-10-02 2010-09-29 Meiji Seika Kaisha Ltd. Antibacterial medicinal composition of enhanced oral absorptivity
EP1858488B2 (en) 2005-03-14 2022-07-20 Wyeth LLC Tigecycline compositions and methods of preparation
EP1954253A4 (en) * 2005-06-08 2011-07-27 Elan Pharma Int Ltd NANOTEILIC AND CONTROLLED RELEASED COMPOSITIONS WITH CEFDITORS
JP2007106684A (ja) * 2005-10-11 2007-04-26 Sawai Pharmaceutical Co Ltd 抗菌性医薬組成物
EP1952803A1 (en) 2007-01-23 2008-08-06 KTB-Tumorforschungs GmbH Solid pharmaceutical dosage form containing hydrogenated phospholipids
EP2373344B1 (en) * 2008-12-08 2016-03-30 F. Hoffmann-La Roche AG Combined drug administration
CA2844367C (en) * 2011-06-24 2016-02-16 Acenda Pharma, Inc. Method and improved pharmaceutical composition for improving the absorption of an ester prodrug
KR101561963B1 (ko) * 2013-05-23 2015-10-22 영진약품공업 주식회사 세프디토렌 피복실의 신규 결정 형태 및 이의 제조 방법
WO2016114727A1 (en) * 2015-01-16 2016-07-21 Öğün Yusuf Toktamiş Cefditoren pivoxil compositions with improved stability and production methods thereof
CN110143957B (zh) * 2019-06-20 2020-12-25 重庆医药高等专科学校 头孢妥仑匹酯开环物的制备方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE58487B1 (en) 1984-09-07 1993-09-22 Kaisha Maiji Seika New cephalosporin compounds and the production thereof
JPS6216431A (ja) * 1985-07-15 1987-01-24 Nakanishi Michio 医薬組成物
JPS62205088A (ja) 1986-03-03 1987-09-09 Meiji Seika Kaisha Ltd 新規セフエム化合物
US5651991A (en) 1987-10-28 1997-07-29 Nippon Shinyaku Co. Ltd. Drug carriers
WO1990015609A1 (en) * 1989-06-15 1990-12-27 Med-Tal, Inc. Prevention and treatment of microbial infection by phosphoglycerides
JP2785981B2 (ja) 1989-11-20 1998-08-13 株式会社資生堂 乳化組成物
US5319116A (en) 1992-02-12 1994-06-07 Gary Viole Lecithin fractions and dilutions, methods for their preparation and pharmacological uses thereof
US6113921A (en) 1993-03-23 2000-09-05 Pharmos Corp. Topical and transdermal delivery system utilizing submicron oil spheres
JPH0717866A (ja) * 1993-06-16 1995-01-20 Meiji Seika Kaisha Ltd 医薬組成物
JPH0840907A (ja) 1994-08-03 1996-02-13 Meiji Seika Kaisha Ltd セファロスポリン注射剤
AR004014A1 (es) 1995-10-13 1998-09-30 Meiji Seika Kaisha Una composicion antibacteriana de cefditoren pivoxilo para administracion oral y metodo para obtener dicha composicion
EP0948341A4 (en) 1996-09-17 2003-05-21 Supergen Inc DERIVATIVES OF PHOSPHOLIPIDE MEDICINES
US6165997A (en) * 1997-11-20 2000-12-26 Statens Serum Institut Phospholipids having antimicrobial activity with or without the presence of antimicrobials
ES2153786B1 (es) * 1999-06-10 2001-10-16 S A L V A T Lab Sa Composicion farmaceutica liquida para la administracion oral de principios activos amargos y susceptibles de hidrolisis.

Similar Documents

Publication Publication Date Title
JP4875277B2 (ja) 放出ｐＨ域及び／又は速度制御組成物
WO2003047519A3 (en) 'compressed annular tablet with molded triturate tablet for oral and intraoral'
WO2005065069A3 (en) Pharmaceutical methods, dosing regimes and dosage forms for the treatment of alzheimer's disease
WO2011110939A2 (en) Pharmaceutical compositions of substituted benzhydrylpiperazines
JP2005515966A5 (https=)
RU2003100507A (ru) Фармацевтические композиции
ATE359777T1 (de) Fenofibratsäure enthaltende pharmazeutische zusammensetzung und deren physiologisch verträgliche salze und derivate
JP2002541187A5 (https=)
CN101795673A (zh) 增强的拉莫三嗪制剂
WO2007079082A3 (en) Gastric release pulse system for drug delivery
ATE298324T1 (de) Deuterierte 3-piperidinopropiophenone sowie diese verbindungen enthaltende arzneimittel
EP2022497B1 (en) Oral composition comprising 3-[5-[4-(cyclopentyloxy) -2-hydroxybenzoyl]-2-](3-hydroxy-1,2-benzisoxazol-6- yl)methoxy¨phenyl¨propionic acid or salt thereof
RU2002100058A (ru) Кристаллические производные 1-метилкарбапенема
JP2005515155A5 (https=)
CA2483002A1 (en) New pharmaceutical composition
CA2449002A1 (en) Enhancement of oral bioavailability of non-emulsified formulation of prodrug esters with lecithin
JP4526247B2 (ja) 経口用セファロスポリン製剤
CA2603783C (en) Pharmaceutical compositions having improved dissolution profiles for poorly soluble drugs
US8529946B2 (en) Rapidly disintegrating antihistamine formulation
US20060089391A1 (en) Treatment of cancer in pediatric patients
WO2004030673A1 (ja) 経口吸収性が改善された抗菌性医薬組成物
WO2004004737A1 (ja) 経口用セファロスポリン製剤
CA2368352A1 (en) Method for treating neurodegeneration
WO2013100878A1 (en) Pharmaceutical formulations comprising aripiprazole
JP4731941B2 (ja) 経口製剤用粒子